# Mgso4 as Neuroprotective in Post Traumatic Brain Injury

> **NCT04646876** · PHASE3 · COMPLETED · sponsor: **Osama Mohamed Abdelwahab** · enrollment: 60 (actual)

## Conditions studied

- Magnesium Sulphate
- Traumatic Brain Injury
- Brain
- Injury

## Interventions

- **DRUG:** Magnesium Sulfate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04646876
- **Lead sponsor:** Osama Mohamed Abdelwahab
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-02
- **Primary completion:** 2020-03-12
- **Final completion:** 2020-06-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04646876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04646876, "Mgso4 as Neuroprotective in Post Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04646876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*